Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma.

Autor: Pomella, Silvia^1,2 (AUTHOR), Danielli, Sara G.³ (AUTHOR), Alaggio, Rita⁴ (AUTHOR), Breunis, Willemijn B.³ (AUTHOR), Hamed, Ebrahem⁵ (AUTHOR), Selfe, Joanna⁶ (AUTHOR), Wachtel, Marco³ (AUTHOR), Walters, Zoe S.⁷ (AUTHOR), Schäfer, Beat W.³ (AUTHOR), Rota, Rossella¹ (AUTHOR), Shipley, Janet M.⁶ (AUTHOR), Hettmer, Simone^5,8,9 (AUTHOR) simone.hettmer@uniklinik-freiburg.de

Publikováno v: Cancers. May2023, Vol. 15 Issue 10, p2823. 30p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study

Autor: Ruhen, Olivia, Lak, Nathalie S M, Stutterheim, Janine, Danielli, Sara G, et al, Surdez, Didier, Schäfer, Beat W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa2001bbd4fba81a49b7a4a79639987
https://www.zora.uzh.ch/id/eprint/226891/

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Autor: Ruhen O; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Lak NSM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Experimental Immunohematology, Sanquin, Amsterdam, the Netherlands., Stutterheim J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Experimental Immunohematology, Sanquin, Amsterdam, the Netherlands., Danielli SG; Department of Oncology and Children's Research Centre, University Children's Hospital, Zurich, Switzerland., Chicard M; SiRIC RTOP (Recherche Translationelle en Oncologie Pediatrique), Institut Curie, Paris, France., Iddir Y; SiRIC RTOP (Recherche Translationelle en Oncologie Pediatrique), Institut Curie, Paris, France., Saint-Charles A; SiRIC RTOP (Recherche Translationelle en Oncologie Pediatrique), Institut Curie, Paris, France., Di Paolo V; Department of Pediatric Haematology/Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Tombolan L; Institute of Pediatric Research, Fondazione Città della Speranza, Padova, Italy., Gatz SA; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Aladowicz E; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Proszek P; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Molecular Diagnostics, Royal Marsden NHS Foundation Trust, London, United Kingdom., Jamal S; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Molecular Diagnostics, Royal Marsden NHS Foundation Trust, London, United Kingdom., Stankunaite R; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Molecular Diagnostics, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom., Hughes D; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Molecular Diagnostics, Royal Marsden NHS Foundation Trust, London, United Kingdom., Carter P; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Molecular Diagnostics, Royal Marsden NHS Foundation Trust, London, United Kingdom., Izquierdo E; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Molecular Diagnostics, Royal Marsden NHS Foundation Trust, London, United Kingdom., Wasti A; Children & Young People's Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Chisholm JC; Children & Young People's Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., George SL; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Children & Young People's Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Pace E; Children & Young People's Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Department of Diagnostic Radiology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Chesler L; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Children & Young People's Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Aerts I; SiRIC RTOP (Recherche Translationelle en Oncologie Pediatrique), Institut Curie, Paris, France., Pierron G; SiRIC RTOP (Recherche Translationelle en Oncologie Pediatrique), Institut Curie, Paris, France., Zaidi S; INSERM U830, Équipe Labellisée LNCC, PSL Research University, SIREDO Oncology Centre, Institut Curie, Paris, France., Delattre O; INSERM U830, Équipe Labellisée LNCC, PSL Research University, SIREDO Oncology Centre, Institut Curie, Paris, France., Surdez D; INSERM U830, Équipe Labellisée LNCC, PSL Research University, SIREDO Oncology Centre, Institut Curie, Paris, France.; Bone Sarcoma Research Laboratory, Balgrist University Hospital, University of Zurich, Zurich, Switzerland., Kelsey A; Department of Pediatric Histopathology, Manchester University Foundation Trust, Manchester, United Kingdom., Hubank M; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Molecular Diagnostics, Royal Marsden NHS Foundation Trust, London, United Kingdom., Bonvini P; Institute of Pediatric Research, Fondazione Città della Speranza, Padova, Italy., Bisogno G; Department of Woman's and Children's Health, Hematology and Oncology Unit, University of Padova, Padova, Italy., Di Giannatale A; Department of Pediatric Haematology/Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Schleiermacher G; SiRIC RTOP (Recherche Translationelle en Oncologie Pediatrique), Institut Curie, Paris, France.; Department of Pediatric Oncology, Hospital Group, Institut Curie, Paris, France., Schäfer BW; Department of Oncology and Children's Research Centre, University Children's Hospital, Zurich, Switzerland., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Experimental Immunohematology, Sanquin, Amsterdam, the Netherlands., Shipley J; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2022 Oct; Vol. 6, pp. e2100534.